Biotimize

Biotimize is a specialized biologics CDMO bridging the gap between early-stage discovery and GMP compliance for Global Biotechs and Pharmaceutical companies.

Accelerating Biomanufacturing from DNA to Clinical Readiness

Scroll Down for more

Biotimize is Brazil's premier CDMO specializing in bioprocess development, cell line engineering, and non-clinical readiness for complex biopharmaceuticals.

We bridge the critical gap between early-stage discovery and scalable, GMP-compliant industrial production (TRL 6). By combining proprietary cell platforms (mammalian & microbial), structured Quality Assurance, and deep regulatory expertise, we empower biotechs, pharma leaders, and public institutions to de-risk pipeline expansion and fast-track market access.

Strategic Expansion

Expanding Toward GMP Clinical Manufacturing
Future-Proofing Infrastructure: As part of our long-term growth masterplan, Biotimize is advancing the development of a 20,000+ m² GMP production site designed to scale R&D and commercial biomanufacturing capabilities, reinforcing our commitment to providing integrated end-to-end solutions for global partners.

Latest News

Bioprocess CDMO Institutional Partners Research
18, Sep 2026
O novo Expedited IND Pilot Program do FDA

BR O novo Expedited IND Pilot Program do FDA e os impactos na agilidade clínica para o desenvolvimento de bioterápicos   Como a iniciativa do FDA para acelerar ensaios First-in-Human eleva a exigência técnica sobre o desenvolvimento do processo de fabricação do IFA e a estratégia regulatória das biotechs.   O ecossistema global de inovação… Continue reading O novo Expedited IND Pilot Program do FDA

Bioprocess CDMO Institutional Partners Research
18, Sep 2026
Lei BIOSECURE: Por que a Resiliência e o Nearshoring Redefinirão o Mercado de CDMOs

BR Lei BIOSECURE: Por que a Resiliência e o Nearshoring Redefinirão o Mercado de CDMOs O mercado global de biotecnologia e desenvolvimento farmacêutico está atravessando o seu maior realinhamento geopolítico das últimas décadas. A recente ação judicial movida pela gigante de biomanufatura WuXi AppTec contra o Departamento de Defesa dos EUA — contestando sua inclusão… Continue reading Lei BIOSECURE: Por que a Resiliência e o Nearshoring Redefinirão o Mercado de CDMOs

Bioprocess CDMO Institutional Partners Research
18, Sep 2026
Além do Transacional: Por que Parcerias Colaborativas são o Futuro do Setor Biotecnológico na América Latina

BR O mercado farmacêutico global atingiu um ponto de inflexão. Se antes as CDMOs (Contract Development and Manufacturing Organizations) eram vistas apenas como uma alternativa para suprir picos de demanda ou reduzir custos fixos, hoje elas são o núcleo da estratégia de lançamento de novos produtos. Para ilustrar essa realidade, basta olharmos para os dados… Continue reading Além do Transacional: Por que Parcerias Colaborativas são o Futuro do Setor Biotecnológico na América Latina

Tell us about your molecule, development stage, or bioprocess challenge

Our technical team will evaluate how Biotimize can support your next development milestone.

Location: Piracicaba, SP — Brazil

LGPD

Rigorous company in relation to the general data protection law (LGPD)

Biotimize - Biotechnology as a Service is committed to complying with the laws that protect the privacy of the data of its employees, partners and the general public.
See how we deal with the information collected:

What are the data types? Personal data:
”Information related to the identified or viral person”, for example: first name, last name, date of birth, personal documents, home or business address, telephone, email and IP address.

Sensitive Personal data:
These are the data that refer to racial or ethnic origin, religious conviction, political opinion, union affiliation or organization of a religious, philosophical or political nature. Sensitive personal data as well are those related to health or sex life, genetic or biometric data.

What data does our Company collect? Our company handles data from employees, partners and service providers, being duly compliant with the LGPD.
On the website, the company collects data through the voluntary and consensual completion of forms, e-books and contact to receive the newsletter.

Is there automatic data collection? Biotimize - Biotechnology as a Service does not automatically collect data in each access to the website.

How do they use my data? The personal data provided by users who fill in the forms are used solely to provide feedback at the user's request (individual or legal entity interested in our company's products and services).
Once the service is completed, such data is deleted.

Have you got any questions? Talk to the Data Protection Manager (DPO) by email: dpo@biotimize.com.br
You will be able to clarify doubts related to the processing of personal data.